HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Yamamoto Selected Research

2- ((8- chlorodibenzo(b,f)thiepin- 10- yl)oxy)- N- methylethan- 1- amine

6/2010Norzotepine, a major metabolite of zotepine, exerts atypical antipsychotic-like and antidepressant-like actions through its potent inhibition of norepinephrine reuptake.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Yamamoto Research Topics

Disease

42Neoplasms (Cancer)
08/2021 - 01/2000
29Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 09/2000
17Infections
04/2014 - 01/2000
11Neoplasm Metastasis (Metastasis)
07/2014 - 02/2000
8Lung Neoplasms (Lung Cancer)
11/2017 - 02/2000
8Neutropenia
11/2017 - 09/2000
7Breast Neoplasms (Breast Cancer)
07/2018 - 01/2000
7Glioma (Gliomas)
02/2009 - 01/2000
6Disease Progression
01/2021 - 12/2000
6Body Weight (Weight, Body)
04/2019 - 09/2003
6Squamous Cell Carcinoma of Head and Neck
05/2017 - 04/2000
5Sarcoma (Soft Tissue Sarcoma)
08/2021 - 05/2000
5Carcinogenesis
04/2019 - 04/2001
5Leukopenia
11/2017 - 08/2001
5Asthma (Bronchial Asthma)
12/2011 - 11/2000
5T-Cell Leukemia (Leukemia, T Cell)
12/2001 - 09/2000
5Inflammation (Inflammations)
06/2001 - 04/2000
4Colorectal Neoplasms (Colorectal Cancer)
04/2016 - 08/2002
4Hepatocellular Carcinoma (Hepatoma)
01/2012 - 07/2000
4Ischemia
10/2001 - 02/2000
3Nausea
11/2017 - 11/2013
3Schizophrenia (Dementia Praecox)
10/2015 - 06/2010
3Exanthema (Rash)
11/2013 - 09/2006
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2013 - 03/2004
3Carcinoma (Carcinomatosis)
06/2010 - 04/2000
3Atopic Dermatitis (Atopic Eczema)
12/2006 - 11/2003
3Hypersensitivity (Allergy)
11/2000 - 04/2000
2Rectal Neoplasms (Rectal Cancer)
05/2019 - 01/2019
2Acquired Immunodeficiency Syndrome (AIDS)
11/2017 - 05/2001
2Abscess
05/2017 - 02/2005
2Wounds and Injuries (Trauma)
01/2017 - 06/2009
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2017 - 08/2004
2Febrile Neutropenia
01/2017 - 10/2015
2Pneumonia (Pneumonitis)
01/2017 - 07/2002
2Adenocarcinoma of Lung
11/2016 - 10/2014
2Anemia
10/2015 - 06/2013
2Atrophy
09/2015 - 09/2013
2Erythema
09/2015 - 01/2005
2Pancreatic Neoplasms (Pancreatic Cancer)
04/2014 - 11/2012
2Hepatitis
04/2014 - 05/2000
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
04/2014 - 03/2001
2Hypertension (High Blood Pressure)
04/2014 - 05/2013
2Diabetic Nephropathies (Diabetic Nephropathy)
04/2014 - 07/2005
2Rheumatoid Arthritis
03/2014 - 01/2001
2Type 2 Diabetes Mellitus (MODY)
10/2013 - 10/2013
2Anorexia
06/2013 - 04/2012
2Adenocarcinoma
06/2013 - 04/2001
2Thymoma (Thymic Carcinoma)
01/2012 - 01/2001

Drug/Important Bio-Agent (IBA)

12Messenger RNA (mRNA)IBA
10/2015 - 07/2000
10Cisplatin (Platino)FDA LinkGeneric
12/2019 - 09/2000
7Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 10/2001
7ErbB Receptors (EGF Receptor)IBA
01/2021 - 06/2003
7Docetaxel (Taxotere)FDA Link
12/2019 - 08/2001
7Peptides (Polypeptides)IBA
10/2004 - 01/2000
6Carboplatin (JM8)FDA LinkGeneric
01/2021 - 10/2001
6Pharmaceutical PreparationsIBA
04/2014 - 02/2000
6NF-kappa B (NF-kB)IBA
06/2001 - 01/2000
5Tyrosine Kinase InhibitorsIBA
12/2019 - 06/2003
5Gefitinib (Iressa)FDA Link
12/2019 - 06/2003
5Proteins (Proteins, Gene)FDA Link
10/2015 - 05/2000
5Biomarkers (Surrogate Marker)IBA
01/2014 - 01/2012
5Chemokine ReceptorsIBA
08/2001 - 12/2000
4Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2021 - 04/2012
4DNA (Deoxyribonucleic Acid)IBA
03/2011 - 04/2000
4Irinotecan (Camptosar)FDA LinkGeneric
02/2009 - 07/2002
4T140 peptideIBA
08/2001 - 12/2000
4AntigensIBA
01/2001 - 01/2000
3Bevacizumab (Avastin)FDA Link
01/2021 - 12/2016
3NivolumabIBA
01/2021 - 12/2016
3EnzymesIBA
04/2016 - 12/2001
3Dexamethasone (Maxidex)FDA LinkGeneric
01/2016 - 09/2000
3ARQ 197IBA
10/2015 - 06/2013
3GemcitabineFDA Link
04/2014 - 06/2004
3Transforming Growth Factor beta (TGF-beta)IBA
04/2010 - 04/2001
3Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2006 - 11/2000
3Immunoglobulin G (IgG)IBA
01/2005 - 04/2000
3SteroidsIBA
08/2001 - 11/2000
3Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2001 - 06/2000
2alectinibIBA
01/2022 - 01/2016
2Green Fluorescent ProteinsIBA
04/2019 - 02/2009
2Drug CombinationsIBA
12/2016 - 12/2008
2AfatinibIBA
11/2016 - 04/2012
2CarbonIBA
09/2015 - 01/2005
2MicroRNAs (MicroRNA)IBA
07/2014 - 11/2013
2Cytochrome P-450 CYP2C19IBA
11/2013 - 06/2013
2Glycoside Hydrolase InhibitorsIBA
10/2013 - 10/2013
2AcarboseFDA LinkGeneric
10/2013 - 10/2013
2ParaffinIBA
06/2013 - 02/2002
2Histones (Histone)IBA
06/2013 - 11/2012
2Lysine (L-Lysine)FDA Link
06/2013 - 11/2012
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2012 - 01/2001

Therapy/Procedure

22Drug Therapy (Chemotherapy)
01/2021 - 05/2000
21Therapeutics
01/2021 - 01/2000
8Radiotherapy
01/2017 - 09/2000
3Liver Transplantation
04/2019 - 04/2014
3Chemoradiotherapy
01/2019 - 05/2000
3Intravenous Infusions
03/2014 - 09/2000
2Immunotherapy
08/2021 - 11/2017
2Neoadjuvant Therapy
01/2019 - 07/2018
2Transplantation
04/2014 - 10/2005